Taking the above into account, the combination of LDH-A and GLUT-1 inhibitors can enhance their influence on cancer metabolism, not only through the blockade of cellular energy production but also by limiting cellular access to the main substrate for its production. This evidence concerns the gene LDHA and cancer.